Australian patient travels 9,000 miles for a cure

March 7, 2019 | Michael Easterling

Australian lobster fisherman David Thompson traveled 9,000 miles for treatment at City of Hope after being diagnosed with Stage 4 oropharyngeal cancer. Given just six weeks to live, he is thriving more than a year after participating in an immunotherapy clinical trial.

Continue Reading

Meet Kim Margolin, M.D.: Leading the fight against melanoma - and winning

May 28, 2018 | Maxine Nunes

When Kim Margolin, M.D., talks about her work, the words are packed with information and pour out with energy and passion. It’s easy to see what makes her an internationally recognized leader in the fight against melanoma.

Peter P. Lee, M.D.: Chasing Cancer from All Angles

February 8, 2017 | Abe Rosenberg

In Peter Lee's latest project, he directs a diverse, far-flung team that's examining breast tumors' so-called “microenvironment,” or the non-cancerous cells that surround and support the tumor, and how they affect the immune system.

Peter P. Lee, M.D. On His Multidisciplinary Approach to Cancer Research

February 8, 2017 | Abe Rosenberg

Peter Lee is leading a multidisciplinary team seeking to learn how breast tumors and their microenvironment affect the immune system.

Advances: New Immunotherapy Treatments for Breast Cancer in 2017

December 23, 2016 | Katie Neith

Peter P. Lee, M.D., a City of Hope oncologist, has for 20 years been interested in treating cancer by stimulating or enhancing a person’s own immune system. This approach, called immunotherapy, has gained much attention in recent years. Lee's outlook for 2017 is full of promise for a more personalized approach to the disease.